{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:04:17Z","timestamp":1791893057525,"version":"4.3.4"},"reference-count":13,"publisher":"The Japanese Society for Neuroendovascular Therapy","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NOUSHINKEI KEKKANNAI TIRYOU","JNET"],"published-print":{"date-parts":[[2025]]},"DOI":"10.5797\/jnet.cr.2025-0090","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:08:04Z","timestamp":1757714884000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["Utilizing Argatroban for Neuroendovascular Therapy in Heparin-Induced Thrombocytopenia: A Case Report and Technical Review"],"prefix":"10.5797","volume":"19","author":[{"given":"Hiroki","family":"Eguchi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Ishiguro","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Omura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Momozaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostadin","family":"Karagiozov","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Nishitani","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takakazu","family":"Kawamata","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Women\u2019s Medical University Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3804","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Warkentin TE, Sheppard JA, Horsewood P, et al. Impact of the patient population on the risk for heparin-induced thrombocytopenia. <i>Blood<\/i> 2000; 96: 1703\u20131708.","DOI":"10.1182\/blood.V96.5.1703.h8001703_1703_1708"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. <i>N Engl J Med<\/i> 2001; 344: 1286\u20131292.","DOI":"10.1056\/NEJM200104263441704"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Cognard C, Gobin YP, Pierot L, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. <i>Radiology<\/i> 1995; 194: 671\u2013680.","DOI":"10.1148\/radiology.194.3.7862961"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Alaraj A, Tobin M, Birk D, et al. Role of argatroban during neurointerventional procedures in patients with heparin induced thrombocytopenia. <i>J Neurointerv Surg<\/i> 2014; 6: 630\u2013632.","DOI":"10.1136\/neurintsurg-2013-010712"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kim S, Ohtaki M, Tsuda H, et al. A case of carotid artery stenting following heparin-induced thrombocytopenia development. <i>J Neuroendovasc Ther<\/i> 2015; 9: 305\u2013309. (in Japanese)","DOI":"10.5797\/jnet.cr.2015-0045"},{"key":"6","unstructured":"6) Dean A, Zyck S, Gould G, et al. Good outcome following catastrophic cerebral sinus thrombosis due to heparin-induced thrombocytopenia: case report and review of literature. <i>Ann Clin Case Rep<\/i> 2018; 3: 1517."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fukushima Y, Takahashi K, Nakahara I. Successful endovascular therapy for cerebral venous sinus thrombosis accompanied by heparin-induced thrombocytopenia. <i>Interv Neuroradiol<\/i> 2020; 26: 341\u2013345.","DOI":"10.1177\/1591019919887821"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Duffau H, Lopes M, Janosevic V, et al. Early rebleeding from intracranial dural arteriovenous fistulas: report of 20 cases and review of the literature. <i>J Neurosurg<\/i> 1999; 90: 78\u201384.","DOI":"10.3171\/jns.1999.90.1.0078"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) S\u00f6derman M, Pavic L, Edner G, et al. Natural history of dural arteriovenous shunts. <i>Stroke<\/i> 2008; 39: 1735\u20131739.","DOI":"10.1161\/STROKEAHA.107.506485"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ishiguro T, Satow T, Hamano E, et al. Outcome of endovascular therapy aiming for single-session obliteration of intracranial dural arteriovenous fistulas. <i>Neurol Med Chir (Tokyo)<\/i> 2021; 61: 563\u2013569.","DOI":"10.2176\/nmc.oa.2021-0059"},{"key":"11","unstructured":"11) GlaxoSmithKline. PRESCRIBING INFORMATION: ARGATROBAN Injection."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kato M, Kotoda A, Akimoto T, et al. Argatroban as a substitute for heparin during PTA for stenotic arteriovenous fistula: a report of a case with heparin-induced thrombocytopenia. <i>Nihon Toseki Igakkai Zasshi<\/i> 2011; 44: 169\u2013172. (in Japanese)","DOI":"10.4009\/jsdt.44.169"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sangawa K, Sekikawa K. Argatroban as a substitute for heparin during VAIVT for a patient with heparin-induced thrombocytopenia. <i>Nihon Toseki Igakkai Zasshi<\/i> 2018; 51: 459\u2013462. (in Japanese)","DOI":"10.4009\/jsdt.51.459"}],"container-title":["Journal of Neuroendovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/19\/1\/19_cr.2025-0090\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T04:24:08Z","timestamp":1757737448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/19\/1\/19_cr.2025-0090\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5797\/jnet.cr.2025-0090","relation":{},"ISSN":["1882-4072","2186-2494"],"issn-type":[{"value":"1882-4072","type":"print"},{"value":"2186-2494","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.2025-0090"}}